Aurinia Pharmaceuticals Inc (AUPH)

[somerssalt]

MarketEdge just upgraded AUPH from NEUTRAL to LONG:

"The technical condition of the stock is supportive of higher prices. The stock remains in demand and support levels should hold as the trend continues higher. The stock has outperformed the market over the last 50 trading days when compared to the S&P 500. The MACD-LT is confirming that the intermediate-term trend is bullish. AUPH's chart formation indicates a strong rising trend. Upside momentum, as measured by the 9-day RSI indicator is positive but is beginning to slow. Over the last 50 trading sessions, there has been more volume on up days than on down days, indicating that AUPH is under accumulation, which is a bullish condition. The stock is trading above a rising 50-day moving average. This validates the strong technical condition for AUPH. The stock is above its 200-day moving average which is pointed up indicating that the intermediate term trend is bullish."